Dengue virus NS1 protein conveys pro-inflammatory signals by docking onto high-density lipoproteins.

Arbovirus accessory protein hemorrhagic fever lipoprotein particle molecular pathogenesis virulence factor

Journal

EMBO reports
ISSN: 1469-3178
Titre abrégé: EMBO Rep
Pays: England
ID NLM: 100963049

Informations de publication

Date de publication:
05 07 2022
Historique:
revised: 24 04 2022
received: 10 07 2021
accepted: 27 04 2022
pubmed: 25 5 2022
medline: 8 7 2022
entrez: 24 5 2022
Statut: ppublish

Résumé

The dengue virus nonstructural protein 1 (NS1) is a secreted virulence factor that modulates complement, activates immune cells and alters endothelial barriers. The molecular basis of these events remains incompletely understood. Here we describe a functional high affinity complex formed between NS1 and human high-density lipoproteins (HDL). Collapse of the soluble NS1 hexamer upon binding to the lipoprotein particle leads to the anchoring of amphipathic NS1 dimeric subunits into the HDL outer layer. The stable complex can be visualized by electron microscopy as a spherical HDL with rod-shaped NS1 dimers protruding from the surface. We further show that the assembly of NS1-HDL complexes triggers the production of pro-inflammatory cytokines in human primary macrophages while NS1 or HDL alone do not. Finally, we detect NS1 in complex with HDL and low-density lipoprotein (LDL) particles in the plasma of hospitalized dengue patients and observe NS1-apolipoprotein E-positive complexes accumulating overtime. The functional reprogramming of endogenous lipoprotein particles by NS1 as a means to exacerbate systemic inflammation during viral infection provides a new paradigm in dengue pathogenesis.

Identifiants

pubmed: 35607830
doi: 10.15252/embr.202153600
pmc: PMC10549233
doi:

Substances chimiques

Lipoproteins, HDL 0
Viral Nonstructural Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e53600

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI124493
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI146464
Pays : United States

Informations de copyright

© 2022 The Authors.

Références

Indian J Pathol Microbiol. 2017 Jan-Mar;60(1):66-69
pubmed: 28195094
Prog Lipid Res. 2014 Oct;56:36-46
pubmed: 25107698
J Virol. 2016 Oct 14;90(21):9570-9581
pubmed: 27512066
Biochem Biophys Res Commun. 2007 Nov 3;362(4):1051-6
pubmed: 17825259
Biochemistry. 2016 Jul 12;55(27):3752-62
pubmed: 27332083
Nat Commun. 2018 Dec 7;9(1):5242
pubmed: 30531923
EMBO Rep. 2022 Jul 5;23(7):e53600
pubmed: 35607830
F1000Res. 2016 Jan 19;5:
pubmed: 26918159
Eur J Clin Invest. 2010 Dec;40(12):1131-43
pubmed: 20695882
FASEB J. 2000 Aug;14(11):1603-10
pubmed: 10928995
PLoS Negl Trop Dis. 2015 Sep 03;9(9):e0003904
pubmed: 26334914
Viral Immunol. 2006 Summer;19(2):127-32
pubmed: 16817755
Dis Markers. 2018 Jan 30;2018:8403937
pubmed: 29651328
Sci Rep. 2015 Nov 05;5:16145
pubmed: 26536916
Expert Rev Proteomics. 2018 Jan;15(1):31-40
pubmed: 29113513
Front Pharmacol. 2016 Jan 12;6:318
pubmed: 26793109
Shock. 2004 Mar;21(3):210-21
pubmed: 14770033
Cell Rep. 2019 Feb 5;26(6):1598-1613.e8
pubmed: 30726741
Adv Virus Res. 2003;59:23-61
pubmed: 14696326
PLoS One. 2019 Mar 22;14(3):e0214245
pubmed: 30901375
J Immunol. 1985 Oct;135(4):2805-9
pubmed: 4031501
J Virol Methods. 2004 Nov;121(2):171-80
pubmed: 15381354
J Virol. 1997 Dec;71(12):9608-17
pubmed: 9371625
Sci Transl Med. 2015 Sep 9;7(304):304ra141
pubmed: 26355030
J Lipid Res. 2015 Aug;56(8):1531-42
pubmed: 26022803
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
Lancet. 2019 Jan 26;393(10169):350-363
pubmed: 30696575
Semin Immunopathol. 2017 Jul;39(5):563-574
pubmed: 28401256
J Infect Dis. 2006 Apr 15;193(8):1078-88
pubmed: 16544248
Trop Med Int Health. 2009 May;14(5):576-85
pubmed: 19309479
Clin Chim Acta. 2020 Apr;503:128-135
pubmed: 31981585
Protein Expr Purif. 1995 Aug;6(4):519-27
pubmed: 8527939
Intensive Care Med. 2007 Jan;33(1):13-24
pubmed: 17093985
Immunol Cell Biol. 2007 Jan;85(1):43-5
pubmed: 17130899
PLoS One. 2017 Jun 6;12(6):e0178820
pubmed: 28586397
J Mol Biol. 2005 Jan 28;345(4):759-71
pubmed: 15588824
J Virol. 2021 Jun 10;95(13):e0197420
pubmed: 33827950
PLoS Pathog. 2016 Jul 14;12(7):e1005738
pubmed: 27416066
Biophys J. 2006 Jun 15;90(12):4651-61
pubmed: 16565040
Sci Rep. 2017 Nov 7;7(1):14769
pubmed: 29116169
Biochim Biophys Acta. 2013 Jan;1830(1):2150-9
pubmed: 23032862
Annu Rev Virol. 2018 Sep 29;5(1):227-253
pubmed: 30044715
Clin Infect Dis. 2002 Apr 15;34(8):1150-3
pubmed: 11915007
Pharmacol Ther. 2013 Mar;137(3):341-51
pubmed: 23246719
Biomedica. 2015 Dec 07;36(0):89-97
pubmed: 27622796
Rev Med Virol. 2019 Sep;29(5):e2056
pubmed: 31172625
Proc Natl Acad Sci U S A. 2011 May 10;108(19):8003-8
pubmed: 21518917
Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19111-6
pubmed: 17132743
J Struct Biol. 2016 May;194(2):191-8
pubmed: 26876146
Novartis Found Symp. 2006;277:233-47; discussion 247-53
pubmed: 17319166
J Gen Virol. 2016 Dec;97(12):3103-3119
pubmed: 27902364
Immunol Cell Biol. 2017 May;95(5):491-495
pubmed: 28220810
Pathology. 2019 Feb;51(2):165-176
pubmed: 30598326
Bioessays. 2015 May;37(5):489-94
pubmed: 25761098
PLoS Negl Trop Dis. 2015 Sep 25;9(9):e0004100
pubmed: 26406240
J Thromb Haemost. 2007 Nov;5(11):2291-9
pubmed: 17958746
Eur Biophys J. 2021 May;50(3-4):403-409
pubmed: 33651123
Antiviral Res. 2016 Jun;130:7-18
pubmed: 26944216
Cell Metab. 2017 Jul 5;26(1):2-3
pubmed: 28648980
Am J Trop Med Hyg. 2014 Mar;90(3):449-56
pubmed: 24470564
Biol Chem. 2015 Jun;396(6-7):573-83
pubmed: 25252751
J Infect. 2012 Mar;64(3):325-34
pubmed: 22138554
Clin Vaccine Immunol. 2007 May;14(5):493-504
pubmed: 17329445
Thromb Haemost. 2016 Mar;115(3):646-56
pubmed: 26632672
Clin Chem Lab Med. 2014 Dec;52(12):1695-727
pubmed: 23940067
J Immunol. 2019 Feb 15;202(4):1153-1162
pubmed: 30642979
J Infect Dis. 2002 Oct 15;186(8):1165-8
pubmed: 12355369
Expert Rev Proteomics. 2019 Sep;16(9):749-760
pubmed: 31382838
Trans R Soc Trop Med Hyg. 2020 May 7;114(5):355-364
pubmed: 32125417
Virology. 1989 Jul;171(1):302-5
pubmed: 2525840
J Virol. 2022 Mar 9;96(5):e0166421
pubmed: 34986002
Rev Inst Med Trop Sao Paulo. 2017 Sep 04;59:e65
pubmed: 28876417
J Pers Med. 2018 Oct 03;8(4):
pubmed: 30282955
Sci Transl Med. 2015 Sep 9;7(304):304ra142
pubmed: 26355031
PLoS One. 2012;7(12):e52215
pubmed: 23284941
Virology. 2016 Sep;496:227-236
pubmed: 27348054
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):E3997-4006
pubmed: 24082141
J Gen Virol. 1987 Mar;68 ( Pt 3):853-7
pubmed: 3819700
Curr Opin Infect Dis. 2006 Oct;19(5):429-36
pubmed: 16940865
Trends Mol Med. 2011 Oct;17(10):594-603
pubmed: 21839683
Virol J. 2016 Jul 29;13:131
pubmed: 27473856
Rev Peru Med Exp Salud Publica. 2018 Jan-Mar;35(1):15-24
pubmed: 29924262
J Virol. 1999 Jul;73(7):6104-10
pubmed: 10364366
Curr Opin Infect Dis. 2013 Jun;26(3):284-9
pubmed: 23449140
Rev Med Virol. 2006 Jul-Aug;16(4):263-75
pubmed: 16791836
PLoS Pathog. 2015 Jul 30;11(7):e1005053
pubmed: 26226614
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701

Auteurs

Souheyla Benfrid (S)

Unité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.
Université Paris Descartes Sorbonne, Paris Cité, France.

Kyu-Ho Park (KH)

Unité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.

Mariano Dellarole (M)

Unité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.

James E Voss (JE)

Unité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.

Carole Tamietti (C)

Unité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.

Gérard Pehau-Arnaudet (G)

UTECH UBI, Institut Pasteur and CNRS UMR 3528, Paris, France.

Bertrand Raynal (B)

Molecular Biophysics Facility, CNRS UMR 3528, Institut Pasteur, Paris, France.

Sébastien Brûlé (S)

Molecular Biophysics Facility, CNRS UMR 3528, Institut Pasteur, Paris, France.

Patrick England (P)

Molecular Biophysics Facility, CNRS UMR 3528, Institut Pasteur, Paris, France.

Xiaokang Zhang (X)

Unité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.

Anastassia Mikhailova (A)

HIV Inflammation et Persistance, Institut Pasteur, Paris, France.

Milena Hasan (M)

Cytometry and Biomarkers Unit of Technology and Service, CB UTechS, Paris, France.

Marie-Noëlle Ungeheuer (MN)

ICAReB, Institut Pasteur, Paris, France.

Stéphane Petres (S)

Production and Purification of Recombinant Proteins Facility, Institut Pasteur, Paris, France.

Scott B Biering (SB)

Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, USA.

Eva Harris (E)

Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, USA.

Anavaj Sakuntabhai (A)

Human Genetics, Institut Pasteur, Paris, France.

Philippe Buchy (P)

Virology Unit, Institut Pasteur du Cambodge, Institut Pasteur International Network, Phnom Penh, Cambodia.

Veasna Duong (V)

Virology Unit, Institut Pasteur du Cambodge, Institut Pasteur International Network, Phnom Penh, Cambodia.

Philippe Dussart (P)

Virology Unit, Institut Pasteur du Cambodge, Institut Pasteur International Network, Phnom Penh, Cambodia.

Fasséli Coulibaly (F)

Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic., Australia.

François Bontems (F)

Unité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.
Département de Biologie et Chimie Structurales, Institut de Chimie des Substances Naturelles, CNRS UPR2301, Gif-sur-Yvette, France.

Félix A Rey (FA)

Unité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.

Marie Flamand (M)

Unité de Virologie Structurale, Institut Pasteur and CNRS UMR3569, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH